Your browser doesn't support javascript.
loading
Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.
Sokolowski, E; Turina, C B; Kikuchi, K; Langenau, D M; Keller, C.
Affiliation
  • Sokolowski E; Department of Student Affairs, Oregon State University, Corvallis, OR, USA.
  • Turina CB; 1] Department of Student Affairs, Oregon State University, Corvallis, OR, USA [2] Pediatric Cancer Biology Program, Department of Pediatrics, Papé Family Pediatric Research Institute, Oregon Health and Science University, Portland, OR, USA.
  • Kikuchi K; Pediatric Cancer Biology Program, Department of Pediatrics, Papé Family Pediatric Research Institute, Oregon Health and Science University, Portland, OR, USA.
  • Langenau DM; 1] Division of Molecular Pathology and Cancer Center, Massachusetts General Hospital, Boston, MA, USA [2] Harvard Medical School and Harvard Stem Cell Institute, Boston, MA, USA.
  • Keller C; Pediatric Cancer Biology Program, Department of Pediatrics, Papé Family Pediatric Research Institute, Oregon Health and Science University, Portland, OR, USA.
Oncogene ; 33(15): 1877-89, 2014 Apr 10.
Article in En | MEDLINE | ID: mdl-23665679
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma / Rare Diseases / Drug Discovery Limits: Child / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2014 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rhabdomyosarcoma / Rare Diseases / Drug Discovery Limits: Child / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2014 Document type: Article Affiliation country: United States